levodopa has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kolmančič, K; Živin, M; Zorovic, M | 1 |
| Brismar, K; Hulting, AL; Werner, S | 1 |
| Shi, YF; Xia, P | 1 |
1 trial(s) available for levodopa and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
The growth hormone, prolactin and TSH response to TRH and L-dopa in patients with hyperprolactinaemia and a normal-sized sella turcica may denote a pituitary adenoma.
Topics: Adult; Female; Growth Hormone; Humans; Hyperprolactinemia; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Sella Turcica; Thyrotropin; Thyrotropin-Releasing Hormone | 1990 |
2 other study(ies) available for levodopa and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Effects of L-dopa on expression of prolactin and synaptotagmin IV in 17-beta-estradiol-induced prolactinomas of ovariectomized hemiparkinsonian rats.
Topics: Animals; Estradiol; Female; Levodopa; Ovariectomy; Parkinson Disease, Secondary; Pituitary Gland; Prolactin; Prolactinoma; Rats; Rats, Wistar; Synaptotagmins | 2021 |
Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma.
Topics: Adult; Carbidopa; Female; Humans; Levodopa; Luteinizing Hormone; Metoclopramide; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin | 1989 |